• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

厄瓜多尔的 遗传多样性和耐药性。

Genetic diversity and drug resistance of in Ecuador.

机构信息

Pontificia Universidad Católica del Ecuador, Quito, Unidad de Investigaciones en Biomedicina, Zurita & Zurita Laboratorios, Quito, Servicio de Microbiología y Tuberculosis, Hospital Vozandes, Quito, Ecuador.

Pontificia Universidad Católica del Ecuador, Quito.

出版信息

Int J Tuberc Lung Dis. 2019 Feb 1;23(2):166-173. doi: 10.5588/ijtld.18.0095.

DOI:10.5588/ijtld.18.0095
PMID:30808448
Abstract

BACKGROUND

The genetic diversity of in Quito, Ecuador is not well known.

OBJECTIVE

To investigate mutations related to drug resistance and bacterial genotypes in strains in Ecuador.

DESIGN

This was a retrospective study of isolates from 104 patients. Isolates were phenotypically resistant to rifampicin (RMP) and/or isoniazid (INH). The genotype was determined using 24-locus mycobacterial interspersed repetitive units-variable-number tandem repeats (MIRU-VNTR).

RESULTS

Isolates showed mutations in the B and G genes, and the A promoter. In B, we found 13 genetic alterations at codons 511, 513, 514, 515, 516, 526 and 531. Forty-six (44.2%) RMP-resistant isolates belonged to codon 531. In G, there were nine genetic alterations at codons 296, 312, 314, 315, 322, 324 and 351. Fifty-three (51%) INH-resistant isolates belonged to codon 315. Five mutations not previously described were identified in G: Thr324Ser, Thr314Ala, Ala312Pro, Trp351Stop and deleted G at 296 codon. The Latin American Mediterranean (LAM) (33.7%) and Ghana (30.8%) lineages presented most of the main mutations observed.

CONCLUSION

This is the first report from Ecuador; it describes five new mutations in G and indicates that LAM is the most prevalent lineage.

摘要

背景

厄瓜多尔基多的 遗传多样性尚不清楚。

目的

研究厄瓜多尔 菌株中与耐药性相关的突变和细菌基因型。

设计

这是一项对来自 104 名患者的 104 株分离株的回顾性研究。分离株对利福平(RMP)和/或异烟肼(INH)表型耐药。基因型采用 24 位位点分枝杆菌插入重复单位-可变数串联重复(MIRU-VNTR)确定。

结果

分离株在 B 和 G 基因以及 A 启动子中显示突变。在 B 中,我们在密码子 511、513、514、515、516、526 和 531 处发现了 13 种遗传改变。46(44.2%)RMP 耐药分离株属于密码子 531。在 G 中,在密码子 296、312、314、315、322、324 和 351 处有 9 种遗传改变。53(51%)INH 耐药分离株属于密码子 315。在 G 中发现了五个以前未描述的突变:Thr324Ser、Thr314Ala、Ala312Pro、Trp351Stop 和 296 密码子缺失 G。以前观察到的主要突变中,拉丁美洲地中海(LAM)(33.7%)和加纳(30.8%)谱系最为常见。

结论

这是厄瓜多尔的首次报告;它描述了 G 中的五个新突变,并表明 LAM 是最常见的谱系。

相似文献

1
Genetic diversity and drug resistance of in Ecuador.厄瓜多尔的 遗传多样性和耐药性。
Int J Tuberc Lung Dis. 2019 Feb 1;23(2):166-173. doi: 10.5588/ijtld.18.0095.
2
Genetic diversity of Mycobacterium tuberculosis isoniazid monoresistant and multidrug-resistant in Rio Grande do Sul, a tuberculosis high-burden state in Brazil.巴西南部结核病高负担州南里奥格兰德州结核分枝杆菌异烟肼单耐药和多耐药的基因多样性。
Tuberculosis (Edinb). 2018 May;110:36-43. doi: 10.1016/j.tube.2018.02.009. Epub 2018 Mar 1.
3
Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.土耳其南部耐药临床结核分枝杆菌复合群分离株中异烟肼和利福平耐药性的基因分型分析
Jpn J Infect Dis. 2008 Jul;61(4):255-60.
4
Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates from Xi'an, China.中国西安耐异烟肼结核分枝杆菌分离株的分子特征。
Microb Drug Resist. 2011 Jun;17(2):275-81. doi: 10.1089/mdr.2010.0135. Epub 2011 Mar 9.
5
Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.在一个耐药结核病发病率较低的国家,表型上对利福平敏感的结核分枝杆菌分离株中出现有争议的 rpoB 突变。
BMC Infect Dis. 2019 Jan 3;19(1):3. doi: 10.1186/s12879-018-3638-z.
6
Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.巴西米纳斯吉拉斯州耐多药结核分枝杆菌的遗传多样性与分子流行病学
BMC Infect Dis. 2015 Aug 1;15:306. doi: 10.1186/s12879-015-1057-y.
7
A First Insight into the and Gene Mutations of Multidrug-Resistant Strains from Ecuador.厄瓜多尔多重耐药菌株的 和 基因突变的初步观察
Microb Drug Resist. 2019 May;25(4):524-527. doi: 10.1089/mdr.2018.0203. Epub 2018 Dec 18.
8
Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.结核分枝杆菌耐药抗结核药物的分子和表型特征。
Int J Tuberc Lung Dis. 2013 Aug;17(8):1088-93. doi: 10.5588/ijtld.12.0949.
9
[Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].[评估基因型MTBDR检测法在临床结核分枝杆菌复合群临床分离株中快速检测利福平及异烟肼耐药性的效果]
Mikrobiyol Bul. 2009 Apr;43(2):217-26.
10
The mutations of katG and inhA genes of isoniazid-resistant Mycobacterium tuberculosis isolates in Taiwan.台湾地区异烟肼耐药结核分枝杆菌分离株 katG 和 inhA 基因突变。
J Microbiol Immunol Infect. 2015 Jun;48(3):249-55. doi: 10.1016/j.jmii.2013.08.018. Epub 2013 Nov 1.

引用本文的文献

1
Decoding Ecuadorian Isolates: Unveiling Lineage-Associated Signatures in Beta-Lactamase Resistance via Pangenome Analysis.解读厄瓜多尔分离株:通过泛基因组分析揭示β-内酰胺酶耐药性中与谱系相关的特征
Biomedicines. 2025 Jan 28;13(2):313. doi: 10.3390/biomedicines13020313.
2
Global epidemiology of Mycobacterium tuberculosis lineage 4 insights from Ecuadorian genomic data.全球结核分枝杆菌4型的流行病学:来自厄瓜多尔基因组数据的见解
Sci Rep. 2025 Jan 30;15(1):3823. doi: 10.1038/s41598-025-86079-8.
3
Molecular epidemiology of in Ecuador: Recent advances and future challenges.
厄瓜多尔[疾病名称]的分子流行病学:最新进展与未来挑战。 (你原文中“of”后面缺少具体内容,这里按照格式推测补充了[疾病名称],请根据实际情况调整)
J Clin Tuberc Other Mycobact Dis. 2024 Jul 26;37:100465. doi: 10.1016/j.jctube.2024.100465. eCollection 2024 Dec.
4
Prevalence, drug resistance, and genotypic diversity of the RD subfamily of in Ecuador: a retrospective analysis for years 2012-2016.厄瓜多尔丙型肝炎病毒 RD 亚科的流行率、耐药性和基因多样性:2012-2016 年的回顾性分析。
Front Public Health. 2024 Apr 4;12:1337357. doi: 10.3389/fpubh.2024.1337357. eCollection 2024.
5
A first insight into tuberculosis transmission at the border of Ecuador and Colombia: a retrospective study of the population structure of in Esmeraldas province.初探厄瓜多尔和哥伦比亚边境的结核病传播:对埃斯梅拉达斯省 种群结构的回顾性研究。
Front Public Health. 2024 Feb 7;12:1343350. doi: 10.3389/fpubh.2024.1343350. eCollection 2024.
6
A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.利用基于网络的生物信息学工具对厄瓜多尔分枝杆菌分离株进行基因组耐药性筛选的精准概述。
PLoS One. 2023 Dec 5;18(12):e0294670. doi: 10.1371/journal.pone.0294670. eCollection 2023.
7
Comparative genomics of drug-resistant strains of Mycobacterium tuberculosis in Ecuador.厄瓜多尔耐多药结核分枝杆菌菌株的比较基因组学。
BMC Genomics. 2022 Dec 21;23(1):844. doi: 10.1186/s12864-022-09042-1.
8
Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis.与异烟肼耐药相关突变的系统评价表明结核分枝杆菌临床菌株持续进化及随后分子检测逃避现象的存在,以及多重耐药出现的可能性。
Antimicrob Agents Chemother. 2021 Feb 17;65(3). doi: 10.1128/AAC.02091-20.
9
Population structure and genetic diversity of Mycobacterium tuberculosis in Ecuador.厄瓜多尔结核分枝杆菌的种群结构和遗传多样性。
Sci Rep. 2020 Apr 10;10(1):6237. doi: 10.1038/s41598-020-62824-z.
10
Circulation of Beijing genotype in Latin America and the Caribbean.北京基因型在拉丁美洲和加勒比地区的传播。
Pathog Glob Health. 2019 Dec;113(8):336-351. doi: 10.1080/20477724.2019.1710066. Epub 2020 Jan 5.